FBXL14 and head and neck cancer: Consistently, one group revealed that imipramine blue inhibited head and neck cancer cell invasiveness by enhancing FBXL14-triggered Twist degradation, which indicates that FBXL14 could function as an EMT inhibitor to suppress metastasis in human cancers [98].